Exercise and QUality Diet After Leukemia: The EQUAL Study

• ClinicalTrials.gov Identifier: NCT02244411
• Recruitment Status: Active, not recruiting
• First Posted: September 19, 2014
• Last Update Posted: July 12, 2022
• Sponsor: Memorial Sloan Kettering Cancer Center
• Collaborators: Johns Hopkins University; St. Jude Children's Research Hospital
• Information provided by (Responsible Party): Memorial Sloan Kettering Cancer Center

Study Description

Brief Summary:

The EQUAL study has been designed for adult survivors of childhood acute lymphoblastic leukemia (ALL) who are overweight or obese. The purpose of this study is to see if diet and exercise can help people lose weight and improve other health problems. This two year study will compare two methods of informing participants about ways to lose weight.

Condition or disease	Intervention/treatment	Phase
Adult Survivors of Childhood Leukemia	Behavioral: individual diet & physical activity counselor and website through Healthways at Hopkins; Behavioral: self directed weight loss; Behavioral: questionnaires; Other: fasting blood draw, measurement of height, weight and waist circumference, and blood pressure	Not Applicable

Study Design

• Study Type: Interventional (Clinical Trial)
• Actual Enrollment: 358 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: None (Open Label)
• Primary Purpose: Prevention
• Official Title: Exercise and QUality Diet After Leukemia: The EQUAL Study
• Actual Study Start Date: September 2014
• Estimated Primary Completion Date: September 2023
• Estimated Study Completion Date: September 2023

Arms and Interventions

Arm	Intervention/treatment
Experimental: Intervention group; Participants will be assigned an individual diet & physical activity counselor through Healthways at Hopkins. This counselor will stay with the participant for the 24 months. The primary communication with the counselor will be via website & email. Participants will be encouraged to consume a low-calorie, low-salt diet with 7-12 daily servings of fruits, vegetables & low-fat dairy products. Calorie goals are based upon weight at study entry & whether or not the weight loss goal has been met. Participants will gradually build to ≥ 180 minutes of moderate to vigorous physical activity per week, using the activity of their own choosing & gradually adding bouts of ≥ 10 minutes in length. Monitoring & Counselor Contacts: the first 3 months, the participants are encouraged to log into the web hub on a daily basis to record weight, food intake, & physical activity. Participants who decline or drop out of the intervention program will remain on-study doing home visits & questionnaires.	Behavioral: individual diet & physical activity counselor and website through Healthways at Hopkins; Phone and web-based weight loss intervention (via Healthways at Hopkins counselor and website) focused on increasing physical activity and adhering to a healthy diet. Participants will log diet, physical activity, and weight in web-hub. Counselors will have access to this information to direct participants to goals and achievements.; Behavioral: questionnaires; Participants will complete behavioral questionnaires as well as diet and physical activity assessments through CCSS-based study website as baseline, 12 and 24 months.; Other: fasting blood draw, measurement of height, weight and waist circumference, and blood pressure; During three time periods, at baseline and at 12 and 24 months.
Active Comparator: control group; Participants will receive general information brochures on healthy living and weight loss but will not have access to the Healthways at Hopkins website or counselors.	Behavioral: self directed weight loss; Participants will be given information and links to CDC and American Cancer Society recommendations for healthy eating and physical activity.; Behavioral: questionnaires; Participants will complete behavioral questionnaires as well as diet and physical activity assessments through CCSS-based study website as baseline, 12 and 24 months.; Other: fasting blood draw, measurement of height, weight and waist circumference, and blood pressure; During three time periods, at baseline and at 12 and 24 months.

Outcome Measures

Primary Outcome Measures :

1. Weight loss [ Time Frame: 24 months ]
   Weight loss will be evaluated in an intent-to-treat analysis with a linear mixed effects model with robust standard errors and an unstructured covariance matrix(50) using weight measured at each time points (0, 12 months and 24 months after randomization) as the outcome modeled as a function of time, randomization arm, a history of CRT, gender, age, and race together with interaction terms between time and randomization arm.

Eligibility Criteria

• Ages Eligible for Study: 18 Years and older (Adult, Older Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

Eligibility will be confirmed via the CCSS-based medical record and by a series of questions on the EQUAL website, prior to consent.

• Participation in the CCSS cohort
• Diagnosed with acute lymphoblastic leukemia < 18 years of age
• Cancer free at time of study enrollment
• Current age ≥ 18 years
• A body mass index (BMI) ≥ 25 kg/m2 (overweight or obese), as determined by self-reported height and weight on the most recent CCSS questionnaire
• Internet access and a personal email account
• Able to read and comprehend informed consent

Exclusion Criteria:

• Prior history of congestive heart failure, coronary artery disease, myocardial infarction, stroke, or unstable angina;
• Medical condition for which weight loss might be contraindicated or which would cause weight loss, such as pregnancy, anorexia or bulimia;
• Use of prescription weight loss medication within the previous 6 months
• History of total body irradiation (TBI)

Contacts and Locations

Locations

United States, New York

Memorial Sloan Kettering Cancer Center

New York, New York, United States, 10065

United States, Tennessee

St. Jude Children's Research Hospital

Memphis, Tennessee, United States

Sponsors and Collaborators

Memorial Sloan Kettering Cancer Center

Johns Hopkins University

St. Jude Children's Research Hospital

Investigators

• Principal Investigator: Chaya Moskowitz, PhD; Memorial Sloan Kettering Cancer Center

More Information

Additional Information:

Memorial Sloan Kettering Cancer Center 

• Responsible Party: Memorial Sloan Kettering Cancer Center
• ClinicalTrials.gov Identifier: NCT02244411
• Other Study ID Numbers: 14-164
• First Posted: September 19, 2014
• Last Update Posted: July 12, 2022
• Last Verified: July 2022

Keywords provided by Memorial Sloan Kettering Cancer Center:

EQUAL; Exercise; Diet; Physical activity; 14-164

Additional relevant MeSH terms:

Leukemia; Neoplasms by Histologic Type; Neoplasms